| scholarly article | Q13442814 |
| P50 | author | James E. Crowe, Jr. | Q37366747 |
| Pere Coll | Q42432241 | ||
| John V. Williams | Q55189885 | ||
| Núria Rabella | Q56481004 | ||
| P2093 | author name string | Rodrigo Martino | |
| Jorge Sierra | |||
| Nuria Margall | |||
| Rocío Parody Porras | |||
| Elena Rámila | |||
| Rosa Labeaga | |||
| P2860 | cites work | Viral infections in immunocompromised patients: what's new with respiratory viruses? | Q30309653 |
| Rhinovirus Infections in Hematopoietic Stem Cell Transplant Recipients with Pneumonia | Q30310805 | ||
| A newly discovered human pneumovirus isolated from young children with respiratory tract disease | Q33845279 | ||
| Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients | Q33877782 | ||
| Molecular identification of enterovirus by analyzing a partial VP1 genomic region with different methods | Q33945564 | ||
| Community respiratory virus infections in immunocompromised patients with cancer | Q33950804 | ||
| Prevention and treatment of influenza | Q34103251 | ||
| Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. | Q34217769 | ||
| Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis | Q34468742 | ||
| Diagnosis and epidemiology of community-acquired respiratory virus infections in the immunocompromised host | Q34484528 | ||
| Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling | Q34487398 | ||
| Prevention and treatment of viral infections in stem cell transplant recipients | Q34722706 | ||
| How contagious are common respiratory tract infections? | Q35093149 | ||
| Specific infectious complications after stem cell transplantation | Q35200641 | ||
| Clinical impact and diagnosis of human metapneumovirus infection | Q35632347 | ||
| Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children | Q35697523 | ||
| Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults | Q35922572 | ||
| Use of Oseltamivir to control influenza complications after bone marrow transplantation | Q39199981 | ||
| Low mortality rates related to respiratory virus infections after bone marrow transplantation | Q39199992 | ||
| Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. | Q40279797 | ||
| Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. | Q40535767 | ||
| Respiratory tract viral infections in bone marrow transplant patients | Q40554422 | ||
| Respiratory syncytial virus infection in immunocompromised adults | Q40784239 | ||
| Use of serum substitutes for the growth of four cell lines commonly used for virus isolation | Q41734748 | ||
| Human Metapneumovirus and Community-Acquired Respiratory Illness in Children | Q42381997 | ||
| Human metapneumovirus and chronic obstructive pulmonary disease | Q42551330 | ||
| Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality | Q43577899 | ||
| The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation | Q43890868 | ||
| Definitions of infection for surveillance in long-term care facilities | Q44232951 | ||
| Pulmonary enterovirus infections in stem cell transplant recipients. | Q44537500 | ||
| The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management | Q44606449 | ||
| Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin | Q44923546 | ||
| Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy | Q45115470 | ||
| Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis | Q45695798 | ||
| Human metapneumovirus--an important new respiratory virus | Q45696012 | ||
| Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation. | Q45709068 | ||
| Respiratory syncytial virus in blood and marrow transplant recipients | Q45722158 | ||
| Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient | Q45728987 | ||
| Respiratory virus infections in adults with hematologic malignancies: a prospective study. | Q45729805 | ||
| Respiratory syncytial virus infection following hematopoietic stem cell transplantation | Q45733327 | ||
| Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience | Q45734202 | ||
| Respiratory virus infections in stem cell transplant patients: the European experience | Q45734204 | ||
| Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections | Q45734206 | ||
| Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience | Q45734208 | ||
| Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity | Q45734961 | ||
| Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population | Q45735327 | ||
| Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation | Q45735386 | ||
| Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome | Q45736390 | ||
| Parainfluenza virus type 3 infections in a hematology unit | Q45737985 | ||
| Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment | Q45738791 | ||
| Respiratory virus infections in bone marrow transplant recipients: the European perspective | Q45741856 | ||
| Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience | Q45741859 | ||
| Community respiratory virus infections in patients with hematologic malignancies. | Q45747401 | ||
| Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients | Q45766275 | ||
| Community respiratory virus infections among hospitalized adult bone marrow transplant recipients | Q45769491 | ||
| Influenza A virus infections among hospitalized adult bone marrow transplant recipients. | Q45781442 | ||
| Respiratory virus infection in immunocompromised patients | Q45843978 | ||
| Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. | Q47819070 | ||
| Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. | Q47969214 | ||
| Adenovirus infections in adult recipients of blood and marrow transplants. | Q50586082 | ||
| Pre-emptive ribavirin for 'RSV' in BMT. | Q50586673 | ||
| Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. | Q51683501 | ||
| Supportive Care | Q56609006 | ||
| Conventional respiratory viruses recovered from immunocompromised patients: clinical considerations | Q64381315 | ||
| Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults | Q74687262 | ||
| Enterovirus infections following T-cell depleted allogeneic transplants in adults | Q75197986 | ||
| Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia | Q77343455 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 781-796 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies | |
| P478 | volume | 11 |
| Q30352359 | A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. |
| Q91633846 | A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients |
| Q36781782 | A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation |
| Q37127953 | Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice |
| Q45356266 | An outbreak of respiratory syncytial virus infection in hematopoietic stem cell transplantation outpatients: good outcome without specific antiviral treatment. |
| Q40721939 | BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. |
| Q36871530 | Burden of human metapneumovirus infection in young children |
| Q40340012 | Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes |
| Q97086476 | Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines) |
| Q37687412 | Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation |
| Q30403699 | Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients |
| Q86913408 | Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients |
| Q30400983 | Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT. |
| Q94948689 | Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation |
| Q54204894 | Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. |
| Q35157540 | Cytotoxic T lymphocytes as immune-therapy in haematological practice |
| Q37426542 | Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation |
| Q37136318 | Emerging respiratory agents: new viruses for old diseases? |
| Q95642557 | Enterovirus-Human Rhinovirus as a Leading Cause of ARDS in a Liver Transplant Recipient |
| Q36538868 | Epidemiology of human metapneumovirus |
| Q42245439 | Epidemiology of viral respiratory tract infections in an outpatient haematology facility. |
| Q45367288 | Evaluation of a clinical scoring system and directed laboratory testing for respiratory virus infection in hematopoietic stem cell transplant recipients |
| Q37546601 | Evaluation of the BioFire FilmArray respiratory panel and the GenMark eSensor respiratory viral panel on lower respiratory tract specimens. |
| Q36996637 | Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies |
| Q27021622 | Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus |
| Q39322311 | Frequency of human metapneumovirus infection in hematopoietic SCT recipients during 3 consecutive years |
| Q35018548 | Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients |
| Q26822938 | Human Metapneumovirus: lessons learned over the first decade |
| Q84332772 | Human metapneumovirus |
| Q27694039 | Human metapneumovirus in adults |
| Q43826545 | Human metapneumovirus infection in a hematopoietic transplant recipient |
| Q38853701 | Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review |
| Q41640118 | Human metapneumovirus pneumonia in patients with hematological malignancies. |
| Q42325543 | Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time |
| Q42280051 | Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness |
| Q33722659 | Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients |
| Q30401036 | Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases |
| Q33714717 | Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections |
| Q42267417 | Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. |
| Q40859434 | Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment. |
| Q38603562 | Influenza in Patients with Hematological Malignancies: Experience at Two Comprehensive Cancer Centers. |
| Q36190914 | Influenza virus infections in patients with malignancies -- characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). |
| Q40166040 | Intravenous palivizumab in respiratory syncytial virus infection after hematopoietic stem cell transplant in children |
| Q42262149 | Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo |
| Q80356829 | Life-threatening human metapneumovirus infections in West of Scotland |
| Q37622157 | Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea |
| Q45385030 | Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. |
| Q36439896 | Management of respiratory viral infections in hematopoietic cell transplant recipients |
| Q30400820 | Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian center |
| Q37501564 | Nosocomial infections in patients with cancer. |
| Q98283571 | Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation |
| Q59352908 | Oral versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplantation Recipients |
| Q40750463 | Outbreak of respiratory syncytial virus (RSV) infection in immunocompromised adults on a hematology ward. |
| Q36886930 | Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement |
| Q36578729 | Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index |
| Q30369346 | Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study |
| Q36386176 | Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review |
| Q44221746 | Patient and family education in HSCT: improving awareness of respiratory virus infection and influenza vaccination. A descriptive study and brief intervention |
| Q30412678 | Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients |
| Q35036056 | Predictive value of testing nasopharyngeal samples for respiratory viruses in the setting of lower respiratory tract disease |
| Q37991125 | Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients |
| Q42204784 | Pulmonary complications in hematopoietic SCT: a prospective study. |
| Q40449757 | Rates of Microbiologically Diagnosed Infection and Pathogen Detection in Hematopoietic Stem Cell Transplant Patients. |
| Q41166298 | Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation. |
| Q60958294 | Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant |
| Q47583282 | Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation |
| Q61449841 | Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients |
| Q92799237 | Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient |
| Q49757892 | Respiratory Viruses in Febrile Neutropenic Patients with Respiratory Symptoms |
| Q92916919 | Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies |
| Q34728523 | Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study |
| Q33410539 | Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes |
| Q26829188 | Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients |
| Q37751364 | Respiratory viral infections in transplant and oncology patients |
| Q39574491 | Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index. |
| Q35989482 | Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection |
| Q33785773 | Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. |
| Q41610012 | Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital |
| Q40413531 | Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation |
| Q30424737 | Severe metapneumovirus infections among immunocompetent and immunocompromised patients admitted to hospital with respiratory infection |
| Q41136482 | Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation |
| Q58795571 | Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief mode |
| Q63880417 | Strong Association between Respiratory Viral Infection Early after Hematopoietic Stem Cell Transplantation and the Development of Life-Threatening Acute and Chronic Alloimmune Lung Syndromes |
| Q45376871 | Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program |
| Q42262215 | Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients |
| Q45387087 | Successful treatment of influenza A virus by oseltamivir in bone marrow transplant recipients |
| Q37074844 | Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation |
| Q42738026 | Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene |
| Q89691871 | The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis |
| Q38526922 | The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients. |
| Q90262508 | The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey |
| Q39322513 | The role of next generation sequencing in infection prevention in human parainfluenza virus 3 infections in immunocompromised patients. |
| Q41001772 | Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus |
| Q40591951 | Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial |
| Q90036155 | Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient |
| Q39118448 | Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation |
| Q30234548 | Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies |
| Q52659804 | Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing. |
| Q42224577 | Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome |
| Q37046176 | Why diagnose respiratory viral infection? |
Search more.